0001209191-19-051378.txt : 20191001
0001209191-19-051378.hdr.sgml : 20191001
20191001183236
ACCESSION NUMBER: 0001209191-19-051378
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191001
FILED AS OF DATE: 20191001
DATE AS OF CHANGE: 20191001
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Samar Michael P.
CENTRAL INDEX KEY: 0001775910
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35005
FILM NUMBER: 191130336
MAIL ADDRESS:
STREET 1: C/O ASSEMBLY BIOSCIENCES, INC.
STREET 2: 11711 N. MERIDIAN ST. SUITE 310
CITY: CARMEL
STATE: IN
ZIP: 46032
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ASSEMBLY BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001426800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11711 N. MERIDIAN STREET
STREET 2: SUITE 310
CITY: CARMEL
STATE: IN
ZIP: 46032
BUSINESS PHONE: (212) 554-4388
MAIL ADDRESS:
STREET 1: 11711 N. MERIDIAN STREET
STREET 2: SUITE 310
CITY: CARMEL
STATE: IN
ZIP: 46032
FORMER COMPANY:
FORMER CONFORMED NAME: VENTRUS BIOSCIENCES INC
DATE OF NAME CHANGE: 20080211
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-10-01
0
0001426800
ASSEMBLY BIOSCIENCES, INC.
ASMB
0001775910
Samar Michael P.
C/O ASSEMBLY BIOSCIENCES, INC.
11711 N. MERIDIAN STREET, SUITE 310
CARMEL
IN
46032
0
1
0
0
SVP, Finance and Bus. Ops, PAO
Common Stock
2019-10-01
4
A
0
2500
0.00
A
20327
D
Stock Option (right to buy)
9.31
2019-10-01
4
A
0
5000
0.00
A
2029-10-01
Common Stock
5000
5000
D
Grant of restricted stock units. The restricted stock units vest in four equal installments, assuming continuous service on each vesting date, as follows: October 1, 2020; October 1, 2021; October 1, 2022; and October 1, 2023.
Includes 827 shares acquired under the Assembly Biosciences, Inc. 2018 Employee Stock Purchase Plan on May 14, 2019.
Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% shall vest on the first anniversary of the date of grant, October 1, 2020; and the remaining 75% shall vest in 36 approximately equal monthly installments, with the options becoming fully vested on October 1, 2023.
/s/ John O. Gunderson, as Attorney-in-Fact
2019-10-01